In this new report, we share our thoughts on 2021 and what we expect to see next year. The thoughts are based on our experience and that of our colleagues from healthcare organizations, private equity, investment banking, institutional investing and policy advocacy.
What do we anticipate for 2022?
A continuing surge in healthcare M&A activity as healthcare organizations continue to look for new partners; rural and struggling hospitals will need additional resources; and private equity firms and other investors remain ready to deploy unused capital.
New regulatory challenges from the No Surprises Act and the long-awaited Stark Law update may ultimately benefit both patients and providers, but that doesn’t mean the transition will be easy.
More government enforcement activity after 2021’s ramp-up and the mid-year reveal of the Biden administration’s investigative priorities.
Waller prepared this report to share important insights to the healthcare industry gained through our extensive transactional, regulatory and government enforcement experience. The deals shown on the following pages offer a representative snapshot of Waller’s work with leading healthcare companies and a wide range of healthcare investors.
Whether a current or prospective client, we are here to help your business thrive. Please send us a message and we will respond to your needs as soon as possible.Send us a message